Sanofi (SNY)
(Delayed Data from NSDQ)
$46.75 USD
+1.11 (2.43%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $46.00 -0.75 (-1.60%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth C Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Sanofi has a market cap of $111.93B, which represents its share price of $45.64 multiplied by its outstanding shares number of 2.45B. As a large-cap company, SNY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SNY 46.75 +1.11(2.43%)
Will SNY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNY
Regeneron Stock Rises on Q2 Earnings and Sales Beat, Eylea HD Sales Up
Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down
SNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock?
Other News for SNY
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Top global stories this week: HSBC, AstraZeneca, Nissan among notable names
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Putnam U.S. Large Cap Value Equity Concentrated SMA Q2 2025 Commentary
Experts helping vaccine advisors are reportedly ousted at CDC